Squawk Pod – February 26, 2026

Detailed Summary

Overview

This episode of “Squawk Pod” (2/26/26) dives into three headline interviews from CNBC’s “Squawk Box”:

• Jensen Huang, CEO of Nvidia, discusses Nvidia’s blockbuster earnings, the AI industrial revolution, emerging competition, and the Pentagon’s standoff with Anthropic.
• FDA Commissioner Dr. Marty Makary lays out major policy reforms for rare disease treatment, transparency in drug approvals, and responds to controversy inside the agency.
• Jeff Housenbold, CEO of Beast Industries, details Mr. Beast’s global content empire, addresses prediction market ethics, and unveils moves into fintech and beyond.

Hosts Becky Quick, Joe Kernan, and Andrew Ross Sorkin provide context, ask probing questions, and keep the tone brisk and occasionally playful.

Nvidia’s Jensen Huang: AI’s New Industrial Revolution

Segment: 02:05–09:52

Key Discussion Points

• Nvidia’s Dominance & Growth

  • Nvidia posted 75% YoY revenue growth in its core data center business, holding about 95% market share.
  • Demand for Nvidia chips “is really strong and it’s diverse. It’s coming from all over the place.” (Jensen Huang, 02:45)
  • The AI compute “inflection points” were cited as a driver—originally with ChatGPT; then reasoning AI; now, “Agentix systems” that can actually “do work” (02:45).

• AI is a Universal Disruptor

  • “AI is a new way of doing software and affects every single industry... every industry will be transformed and every country will power it.” (Huang, 04:11)
  • AI’s broadening from chatbots to code, automobiles (robotaxis), scientific computing, across all sectors.

• Competitive Landscape & Law of Large Numbers

  • Becky notes AMD’s deal with Meta and growing competition; new Nvidia chips (“Vera Rubins”) rolling out to hold share (05:24).
  • Panel ponders: Can Nvidia keep up “75% revenue growth”? Is the “law of large numbers” finally catching up? “How do you do a $5 trillion company? I guess it goes to ten trillion.” (Unknown commentator, 06:24)

• Valuation Skepticism

  • Despite meteoric growth, Nvidia’s P/E ratios are lower than other chipmakers. “They may even continue to beat on all metrics next quarter.” (07:26)
  • Stock volatility noted—“At one point up three and a half to four percent... now up by less than 1%.” (Becky Quick, 07:42)

• AI Replacing Jobs

  • Hosts joke about jobs replaced by “GenTech AI”—with some playful ribbing about anchors themselves being replaced.
  • “I think you might be replaced by AI, but yeah, not you.” (Andrew Ross Sorkin, 08:06)
  • “Max Headroom.” (Becky Quick, 08:11)

• Vendor Financing Concerns

  • Huang’s massive cash stockpile ($20 billion increase) helps allay fears about vendor financing risk (08:31).
  • “If you were worried about the vendor financing, that tells you that they have money to spread around.” (Becky Quick, 08:31)

• AI Arms Race

  • AWS, Google, Meta among the hyperscalers needing to spend “$670 billion to build out just their AI infrastructure.” (09:13)

Notable Quotes

• “AI is a new industrial revolution.”
  — Jensen Huang (01:16, repeated at 04:11)
• “The amount of computing demand is off the charts.”
  — Jensen Huang (02:45)

Anthropic, Pentagon, and AI Safety

Segment: 10:27–14:15

Key Discussion Points

• Government vs. AI Startups

  • The Pentagon is pressuring Anthropic for wide-ranging access to its models, considering labeling them a “supply chain risk” (10:27).
  • “Here we are in a standoff that is actually, I think, a much bigger deal than maybe we’re even giving it credit for...” (Andrew Ross Sorkin, 11:12)

• Anthropic’s Safety Commitment

  • Anthropic is viewed as the most safety-conscious AI company, but there are signs “they’re lessening that...to be more competitive.” (Andrew Ross Sorkin, 11:46)
  • “There’s the safety issue...and the fact that they’re lessening that in their...safety bridge.” (11:46)

• Jensen Huang’s Take

  • “The Defense Department has the right to use technology...for their needs...Anthropic, of course, has the right to decide how they market their products. I think they both have their reasonable perspective...If it doesn’t get worked out, it’s also not the end of the world.” (Jensen Huang, 12:27)
  • Reassurance that “AI is not the only game in town” for governments or companies globally.

Notable Quotes

• “I hope they can work it out. But if it doesn’t...it’s also not the end of the world.”
  — Jensen Huang (12:27)
• “Claude and Anthropic, in particular, they’ve been the most worried about safety of all of the companies.”
  — Andrew Ross Sorkin (11:22)

Dr. Marty Makary: FDA Modernization & Rare Disease Reform

Segment: 16:36–30:20

Key Discussion Points

• Rare Disease as a Focus

  • “Rare isn’t really all that rare at all. Rare diseases impact about 30 million Americans.” (Becky Quick, 16:36)
  • Makary spearheading shift from treating rare diseases as an “afterthought” to making them the main focus (17:16).

• Reform Highlights

  • Tax credits, waived application fees, extended exclusivity, plus new “innovation hub” for standardized review.
  • Pediatric Priority Voucher Program renewed, providing $100–$200 million transferable voucher for rare disease drug approvals (14:38, 17:16).
  • “Plausible mechanism pathway”: For ultra-rare diseases, “if there’s a mechanism that makes sense...we’re going to go ahead and green light that therapy.” (Dr. Makary, 18:30)

• Transparency & Accountability

  • “If we reject a drug, the public deserves to know why ...for the first time in history, our letters detailing why a drug has not been accepted ...is now public information in real time.” (Dr. Makary, 20:42)

• Regulatory Flexibility & Speed

  • Moving from traditional randomized control trials toward Bayesian statistics and global data aggregation.
  • Goal: Reduce drug review times “from a year down to a number of weeks.” (Dr. Makary, 22:49)
  • “We’re going from a requirement of two clinical trials down to one. And that alone is going to allow companies to put twice as many drugs through the process.” (Dr. Makary, 22:49)

• Responding to Criticism About FDA Internal Politics

  • Addresses Wall Street Journal’s critique focused on Dr. Vinay Prasad and the role of randomized control trials—a “smear campaign” according to Makary (20:42, 22:49, 24:53).
  • Affirms that randomized trials aren’t always required for rare/life-threatening diseases; flexibility is the new norm (25:59).
  • “If the trial shows no benefit...then there are two sides to that story...that’s why our decision letters are public.” (Dr. Makary, 26:23)

• Defending FDA Talent

  • On Dr. Vinay Prasad: “He’s a genius. He’s on loan from UCSF. He’s published over 500 scientific peer-reviewed articles...” (Dr. Makary, 22:49)
  • Reiterates focus on scientific excellence, not partisan politics.

• Surgeon General Nominee Kasey Means

  • Defense of her stance on vaccines, food as medicine, and “fresh new ideas in health care.” (Dr. Makary, 28:22)

Notable Quotes

• “We decided at the FDA that if we reject a drug, the public deserves to know why. So for the first time in history, our letters...are now public information in real time.”
  — Dr. Marty Makary (00:48, expanded at 20:42)
• “We’re going to have more regulatory flexibilities...if there’s a mechanism that makes sense, we wave all the clinical trial requirements...”
  — Dr. Makary (18:30)
• “Kasey Means is the best person for the job...We need fresh new ideas in health care. And she’s the perfect person for that.”
  — Dr. Makary (28:22)

Beast Industries & Mr. Beast: Beyond YouTube

Segment: 32:01–41:44

Key Discussion Points

• Scale & Reach

  • Mr. Beast is now at “468 million subscribers on YouTube...and over a billion across our platforms.” (Andrew Ross Sorkin & Jeff Housenbold, 33:06)
  • “In the last 90 days alone, 1.5 billion unique people around the world have watched our content. 80% of those outside the United States. Jimmy is a global phenomenon.” (Jeff Housenbold, 33:42)

• Content Platform Evolution

  • Vision: Move from single-creator brand (Mr. Beast “akin to Mickey Mouse”) to a larger entertainment platform, emulating Disney’s multi-character universe (34:59).
  • “We’re moving away from an individual to building an entertainment platform that will allow for other content and other talent to emerge and rise as a star.” (Jeff Housenbold, 34:59)

• Prediction Market Controversy

  • Recent controversy over an employee betting on KALSI regarding Beast Games outcomes; company already had ethics policies in place, employee suspended pending investigation (36:02–36:44).
  • “Prediction markets are going to have to self police, but...that’s not sufficient.” (37:32)
  • “You could be a third party cameraman on set...there’s so much information out there...people are taking advantage of that.” (Jeff Housenbold, 38:39)

• Fintech Move – Acquisition of Step

  • Beast Industries acquired Step, a fintech targeting financial literacy for youth (39:09).
  • Plan is to gamify financial education using Mr. Beast’s reach and appeal to Gen Z/Alpha.

• Web3 & Diversification

  • Beast Industries is invested in BitMine (Ethereum staking, DeFi). “Ethereum is the backbone of Stablecoin and the blockchain. We’re big fans of Ethereum.” (40:45)
  • Plans to expand from media/consumer products to telecoms and financial services.

Notable Quotes

• “There’s seven more billion people to get.”
  — Jeff Housenbold, on growth potential (33:25)
• “Mr. Beast is akin to Mickey Mouse, very important character...but they have Lucas and Star Wars and Marvel...We’re moving away from an individual to building an entertainment platform.”
  — Jeff Housenbold (34:59)
• “Prediction markets are going to have to self police, but I don’t think that's sufficient...It is ripe for abuse and our concern is to protect the little people.”
  — Jeff Housenbold (37:32)
• “We’re going to make [financial literacy] entertaining, we’re going to gamify it...to help drive the habits that lead to long term success for the masses.”
  — Jeff Housenbold (39:09)

Memorable Moments

• Jensen Huang on AI’s Ubiquity:
  “AI is fundamentally a new way of doing software...every single company is affected, every industry will be transformed.” (04:11)

• Dr. Makary on Transparency:
  “If your drug works, it’s going to get approved by the FDA. And let’s just remember, there are moneyed interests.” (20:42)

• Beast CEO on Brand Expansion:
  “Think about Jimmy Donaldson, he’s akin to Walt Disney, a brilliant storyteller using the medium of his time to create content that engages… And Mr. Beast is akin to Mickey Mouse...” (34:59)

• Beast CEO on Prediction Market Dangers:
  “It is ripe for abuse and our concern is to protect the little people...Just like the casino companies have to do.” (37:32)

Timestamps for Key Segments

• Nvidia & Jensen Huang: 02:05–09:52
• Anthropic & Pentagon Showdown: 10:27–14:15
• FDA Commissioner Dr. Makary: 16:36–30:20
• Mr. Beast/Beast Industries & Jeff Housenbold: 32:01–41:44

Overall Tone & Takeaways

• The episode balances optimism about technology and healthcare innovation (Huang, Makary) with pragmatism about risks (vendor financing, AI safety, prediction market abuse).
• Personal asides and quips keep the tone energetic and accessible, especially in the Mr. Beast/Beast Industries and AI segments.
• Policy and tech news are discussed with rare depth, especially on FDA transparency reforms and the ethical challenges of next-gen content and AI.

This summary captures the episode’s structure, central ideas, spirited debate, and provides a guide to key moments for listeners or readers who want an in-depth understanding without hearing the full show.